A mouse model of severe halothane hepatitis based on human risk factors
about
Xenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the LiverDrug-induced hepatotoxicity: metabolic, genetic and immunological basisDrug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or NecrosisIdiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicityNatural killer cells mediate severe liver injury in a murine model of halothane hepatitisHalothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis.Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha.Eosinophils mediate the pathogenesis of halothane-induced liver injury in miceMolecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction.Animal models of idiosyncratic drug-induced liver injury--current status.Role of immune reactions in drug-induced liver injury (DILI).Contributions of caspase-8 and -9 to liver injury from CYP2E1-produced metabolites of halogenated hydrocarbons.Immune Modulation by Volatile AnestheticsCurrent challenges and controversies in drug-induced liver injury.Urinary lipid and protein oxidation products upon halothane, isoflurane, or sevoflurane anesthesia in humans: potential biomarkers for a subclinical nephrotoxicity.Drug-Induced Liver Injury in Children: Clinical Observations, Animal Models, and Regulatory Status.
P2860
Q26800213-4344FE6B-8ABD-4E4B-AB62-BEC11EF87CA0Q26991809-09F8EF6D-56F1-4F97-AB19-50D536F55553Q33755165-524D2195-FD7B-4D10-9A40-02D30F4689DEQ34200596-B36651DC-A28E-4DC0-8364-9CAA70A33486Q34701790-CDB074D6-7280-4A34-9B03-4D1CFB9ED5B2Q35507135-4D4EFEC9-2B75-4BA3-9CAF-73C9C949DB58Q35626791-6B1F3940-5B2B-4375-8ED9-45AF5A0CF4A3Q36724588-2A635FD2-B151-4ECD-A7E3-65021D71C194Q37411993-4E3F797C-0206-4CF1-A6FD-FACEBA3A481FQ37897219-86607286-7B42-49E9-9EF3-559E19BCEC4EQ37974923-CD037A6C-92E6-4C9C-8020-3BF4C95DA9BEQ38721677-C8CA34B5-AE6D-41FE-BB32-3BE0DF0797BCQ38861319-2B5C0855-4E52-4CD1-BF1E-3B3D43DE4DBFQ39523252-1C9F3614-A64F-4E8E-A618-1533CA9B3C5FQ45131046-A5E56129-9542-4885-ACCB-FB779F73A779Q47781069-CCF962E5-23FF-4E98-A38B-5684528E09FC
P2860
A mouse model of severe halothane hepatitis based on human risk factors
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A mouse model of severe halothane hepatitis based on human risk factors
@ast
A mouse model of severe halothane hepatitis based on human risk factors
@en
type
label
A mouse model of severe halothane hepatitis based on human risk factors
@ast
A mouse model of severe halothane hepatitis based on human risk factors
@en
prefLabel
A mouse model of severe halothane hepatitis based on human risk factors
@ast
A mouse model of severe halothane hepatitis based on human risk factors
@en
P2093
P2860
P356
P1476
A mouse model of severe halothane hepatitis based on human risk factors
@en
P2093
Allen E MacDonald
Christine M Dugan
Patricia E Ganey
Robert A Roth
P2860
P304
P356
10.1124/JPET.109.164541
P407
P577
2010-02-02T00:00:00Z